Net Income (Loss) Attributable to Parent in USD of Pelthos Therapeutics Inc. from 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pelthos Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2022 to Q3 2025.
  • Pelthos Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$16.2M, a 858% decline year-over-year.
  • Pelthos Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$23.6M, a 134% decline year-over-year.
  • Pelthos Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$7.96M, a 7.78% decline from 2023.
  • Pelthos Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.38M, a 200% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Pelthos Therapeutics Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$23.6M -$16.2M -$14.5M -858% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$9.04M -$3.45M -$1.68M -94.6% 01 Apr 2025 30 Jun 2025 10-Q 13 Nov 2025
Q1 2025 -$7.36M -$1.97M +$594K +23.2% 01 Jan 2025 31 Mar 2025 10-Q 13 Nov 2025
Q4 2024 -$7.96M -$1.93M +$2.11M +52.3% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 -$10.1M -$1.7M -$273K -19.2% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$9.79M -$1.77M -$819K -85.9% 01 Apr 2024 30 Jun 2024 10-Q 13 Nov 2025
Q1 2024 -$8.98M -$2.56M -$1.6M -165% 01 Jan 2024 31 Mar 2024 10-Q 13 Nov 2025
Q4 2023 -$7.38M -$4.04M 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 -$1.42M 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$953K 01 Apr 2023 30 Jun 2023 10-Q 13 Nov 2024
Q1 2023 -$967K 01 Jan 2023 31 Mar 2023 10-Q 13 Nov 2024

Pelthos Therapeutics Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7.96M -$575K -7.78% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 -$7.38M -$4.92M -200% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 -$2.46M 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.